LSD1 ‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1 ‐Induced p62 Transcription in HCC
Luyuan Ma,An Xu,Lei Kang,Rui Cong,Zhongyi Fan,Xiang Zhu,Nan Huo,Wenpeng Liu,Chunyuan Xue,Quanbo Ji,Wenchao Li,Zhong Chu,Xiaofeng Kang,Yadong Wang,Zhijia Sun,Yuchen Han,Hanxiao Liu,Xiang Gao,Juqiang Han,Hua You,Caiyan Zhao,Xiaojie Xu
DOI: https://doi.org/10.1002/hep.32079
IF: 17.298
2021-10-05
Hepatology
Abstract:Background And AimsOxaliplatin (OXA) is one of the most common chemotherapeutics in advanced hepatocellular carcinoma (HCC), the resistance of which poses a big challenge. Long non-coding RNAs (lncRNAs) play vital roles in chemoresistance. Therefore, elucidating the underlying mechanisms and identifying predictive lncRNAs for OXA resistance is needed urgently. MethodsRNA sequencing and FISH were utilized to investigate the OXA-resistant (OXA-R) lncRNAs. Survival analysis was performed to determine the clinical significance of LINC01134 and p62 expression. Luciferase, RIP, ChIP and ChIRP assays were used to explore the mechanisms by which LINC01134 regulates p62 expression. The effects of LINC01134/SP1/p62 axis on OXA resistance were evaluated using cell viability, apoptosis and mitochondrial function and morphology analysis. Xenografts were used to estimate the in vivo regulation of OXA resistance by LINC01134/SP1/p62 axis. ChIP, cell viability and xenograft assays were used to identify the demethylase for LINC01134 upregulation in OXA resistance. ResultsLINC01134 was identified as one of the most upregulated lncRNAs in OXA-R cells. Higher LINC01134 expression predicted poorer OXA therapeutic effacacy. LINC01134 activates anti-oxidative pathway through p62 by recruiting transcription factor SP1 to the p62 promoter. The LINC01134/SP1/p62 axis regulates OXA resistance by altering cell viability, apoptosis, and mitochondrial homeostasis both in vitro and in vivo. Further, the demethylase, LSD1 was responsible for LINC01134 upregulation in OXA-R cells. In HCC patients, LINC01134 expression was positively correlated with p62 and LSD1 expressions, while SP1 expression positively correlated with p62 expression. ConclusionLSD1/LINC01134/SP1/p62 axis is critical for OXA resistance in HCC. Evaluating LINC01134 expression in HCC will be effective in predicting OXA efficacy. In treatment-naive patients, targeting the LINC01134/SP1/p62 axis may be a promising strategy to overcome OXA chemoresistance.
gastroenterology & hepatology